ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,460.48
-0.41%
Dow Jones
39,118.86
-0.12%
US Dollar vs MXN
18.3386
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,708.89
-0.30%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

  7. China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP) Noticias

NKBP

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) (NKBP)

China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NKBP
FechaHoraFuenteTítuloSímboloCompañía
25/07/201707:00Business WireNantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Pr...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201305:52Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201305:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
07/02/201303:54GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Completion of MergerNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/02/201316:14Edgar (US Regulatory)(25-NSE)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
29/01/201308:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201308:03Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (SC 13E3/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201306:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/01/201303:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/01/201308:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/12/201208:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of ShareholdersNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
25/11/201208:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
05/11/201207:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
12/10/201216:00Edgar (US Regulatory)Statement of Ownership: Private Transaction (SC 13E3)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
06/10/201211:11Business WireRosen Law Firm Announces Investigation of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal from Kin...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/09/201216:15Dow Jones NewsADR Report: Shares End Higher; Resource Firms GainNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
27/09/201208:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private TransactionNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
22/08/201215:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
01/08/201207:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/06/201207:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFONASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
08/06/201209:11Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
04/06/201207:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
23/05/201215:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
21/05/201207:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going P...NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
15/05/201205:20Edgar (US Regulatory)Amended Annual and Transition Report (foreign private issuer) (20-F/A)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
10/05/201208:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. to Report First Quarter 2012 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
09/05/201206:00GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Announces Receipt of "Going Private" ProposalNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
24/04/201215:33Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/03/201222:59GlobeNewswire Inc.CORRECTING and REPLACING -- China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
14/03/201215:01GlobeNewswire Inc.China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial ResultsNASDAQ:NKBPChina Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:NKBP

Su Consulta Reciente

AQSE
CRBL.GB
Lyxor Asset Management L...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados